These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 6361725

  • 21. Initial experience with metolazone. Well tolerated new antihypertensive agent.
    Nichols TO.
    Minn Med; 1977 Aug; 60(8):549-53. PubMed ID: 882083
    [No Abstract] [Full Text] [Related]

  • 22. Metolazone therapy of patients with mild to moderate hypertension.
    Ward W.
    J S C Med Assoc; 1977 Mar; 73(3):99-100. PubMed ID: 266100
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension.
    Dussol B, Moussi-Frances J, Morange S, Somma-Delpero C, Mundler O, Berland Y.
    Nephrol Dial Transplant; 2005 Feb; 20(2):349-53. PubMed ID: 15615808
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Severe electrolyte disturbances associated with metolazone and furosemide.
    Black WD, Shiner PT, Roman J.
    South Med J; 1978 Apr; 71(4):380-1, 385. PubMed ID: 635611
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effects of prolonged administration of metolazone in the treatment of essential hypertension.
    Cangiano JL.
    Curr Ther Res Clin Exp; 1976 Dec; 20(6):745-50. PubMed ID: 827420
    [No Abstract] [Full Text] [Related]

  • 30. Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
    Kult J, Häcker W, Glocke M.
    Arzneimittelforschung; 1988 Jan; 38(1A):212-4. PubMed ID: 3285837
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A comparative randomized double-blind clinical trial of bumetanide and furosemide in congestive cardiac failure and other edema states.
    Sagar S, Sharma BK, Sharma PL, Wahi PL.
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):473-8. PubMed ID: 6389378
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Myocardial calcification and hypertension following chronic renal failure and ameliorative effects of furosemide and captopril.
    Rahman M, Kim SJ, Kim JS, Kim SZ, Lee YU, Kang HS.
    Cardiology; 2010 Sep; 116(3):194-205. PubMed ID: 20689276
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Metolazone in arterial hypertension. Multi-centric study with 2.5 mg of Zaroxolyne (metolazone) taken in a single daily dose].
    Abetel G, Allenbach C, Chapuis P, Christeler P, Delacrétaz B, Karly M, Magnenat G, Morandi D, Muhlbauer MA, de Senarciens B, Terrier P, Troillet F.
    Rev Med Suisse Romande; 1978 Dec; 98(12):685-91. PubMed ID: 366713
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.